type

Documents about type

• Special Survey for Patients With Type 1 or Type 2 Diabetes#18819ClinicalTrials.gov
• Closed Loop Glucose Control in Patients With Type 1 and Type 2 Diabetes#67796ClinicalTrials.gov
• New Type Hyper Groups, New Type SuperHyper Groups and Neutro-New Type SuperHyper Groups#81320PhilArchive
• Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery#127800ClinicalTrials.gov
• AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus#121315ClinicalTrials.gov
• Evaluating a Type 2 Diabetes Prevention Program#123626ClinicalTrials.gov
• Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics#126020ClinicalTrials.gov
• Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes#127817ClinicalTrials.gov
• Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes#141205ClinicalTrials.gov
• Safety and Efficacy of Albiglutide in Type 2 Diabetes#143817ClinicalTrials.gov
• The Rewster: Type Preserving Rewrite Rules for the Rocq Prover#7656HAL (France)
• Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes#143675ClinicalTrials.gov
• Generalization to Type 2 of PSO-Optimized Type 1 PD Fuzzy Controller and its Application to a Quadrotor UAV#14239HAL (France)
• The LoBAG Diet and Type 2 Diabetes Mellitus#67842ClinicalTrials.gov
• WelChol® With Metformin in Treating Patients With Type 2 Diabetes#67853ClinicalTrials.gov
• Autologous SVF Therapy for Type 2 Diabetes#136231ClinicalTrials.gov
• Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes#140938ClinicalTrials.gov
• Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus#141175ClinicalTrials.gov
• Efficacy of Diazoxide in Type 1 Diabetes#141202ClinicalTrials.gov
• Functional regulation and cross-talk of type III and type VI secretion systems in <i>Salmonella</i>#4556Europe PMC
• Type and Presses in America A Brief Historical Sketch of the Development of Type Casting and Press Building in the United States#61781Project Gutenberg
• The Effect of Education Given to Type 2 Diabetics on Diabetes Self-management, Health Fatalism and Metabolic Parameters#146348ClinicalTrials.gov
• Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes Mellitus.#18789ClinicalTrials.gov
• Management of Type 2 Diabetes After Gastric Bypass Surgery#28549ClinicalTrials.gov
• Egg Intake and Risk of Type 2 Diabetes#143728ClinicalTrials.gov
• HbA1c Variability in Type II Diabetes#143806ClinicalTrials.gov
• Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes#143816ClinicalTrials.gov
• Metformin Therapy for Overweight Adolescents With Type 1 Diabetes#28539ClinicalTrials.gov
• iOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes#123665ClinicalTrials.gov
• Cellular Adaptations to Training in Patients With Type 2 Diabetes#126050ClinicalTrials.gov
• Metronom Continuous Glucose Monitoring System#127774ClinicalTrials.gov
• Type 2 Diabetes Haptoglobin Phenotype and Vitamin E#141179ClinicalTrials.gov
• Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects#143775ClinicalTrials.gov
• Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes#143812ClinicalTrials.gov
• Metformin in Overweight Type 2 Diabetes Mellitus#146289ClinicalTrials.gov
• A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus#18555ClinicalTrials.gov
• Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2#28520ClinicalTrials.gov
• Nurse Telephone Management of Cholesterol in Diabetes#67770ClinicalTrials.gov
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes#67811ClinicalTrials.gov
• A Study of LY2599506 in Patients With Type 2 Diabetes#67848ClinicalTrials.gov
• Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus#121295ClinicalTrials.gov
• Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)#121305ClinicalTrials.gov
• Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)#123402ClinicalTrials.gov
• Biweekly Interval Intermittent Fasting for Type 2 Diabetes, a Safety Study#123415ClinicalTrials.gov
• Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus#125990ClinicalTrials.gov
• Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes#126005ClinicalTrials.gov
• Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes#126018ClinicalTrials.gov
• Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients#18809ClinicalTrials.gov
• Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes#28536ClinicalTrials.gov
• A Study of TG103 in Subjects With Type 2 Diabetes#67792ClinicalTrials.gov

Related topics